Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
25 November, 2017 11:22 IST
Jubilant Life' arm to negotiate potential acquisition of speciality biz in USA
Source: IRIS | 21 Mar, 2017, 10.16AM
Comments  |  Post Comment

Jubilant Life Sciences' material wholly owned subsidiary in Singapore, Jubilant Pharma (JPL) has received an approval to negotiate a potential acquisition of a speciality pharma business in the United States using only internal accruals, subject to due diligence, satisfactory agreements, etc. and its final approval. The board of directors of JPL at its meeting has approved for the same.

The proposed acquisition is a niche, profitable speciality pharma business with a strategic fit and is expected to provide competitive edge for JPL's existing business, if it materializes.

Shares of the company gained Rs 7.65, or 0.97%, to trade at Rs 793.00. The total volume of shares traded was 81,616 at the BSE (10.08 a.m., Tuesday).



Jubilant Life Sciences Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Indian Hume Pipe secures order worth Rs 1.19 bn - 24-Nov-2017 15:14
Arshiya signs definitive agreements with Ascendas - 24-Nov-2017 11:20
IMP Powers commissions 20 KW hydro-kinetic project - 24-Nov-2017 10:38
Reliance concludes sale of certain assets operated by Carrizo Oil & Gas - 24-Nov-2017 10:25
Zydus Cadila gets USFDA nod for Minocycline HCl ER tablets - 24-Nov-2017 10:22
Zydus Cadila gets tentative approval for Tadalafil tablets - 24-Nov-2017 10:19
CG Power bags order worth Rs 1.11 bn from Indian Railways - 24-Nov-2017 10:09
Welspun Corp bags order for supply of 392K MTs pipes - 24-Nov-2017 10:04
Thomas Cook to sell 5.42% stake in Quess Corp via OFS - 23-Nov-2017 10:28
Tata Tele subscribers commence transitioning to Airtel network - 23-Nov-2017 10:13
Glenmark Pharma gets nod for generic Loestrin Fe 1/20 tablets - 22-Nov-2017 11:27
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer